Our lawyers continue to help those who have been harmed by Ortho Evra Birth Control Patch
An article in the April 6, 2008 New York Times points out that despite all the risk factors Johnson & Johnson knew about the Ortho Evra birth control patch, it did not move quickly to alert the public. Our lawyers continue to help those who have been harmed by the Patch.
The article states that "The Ortho case, however, suggests that Johnson & Johnson, like other drug makers, is not always quick to tell the F.D.A. about potential problems with its medicines."
The report goes on to say that a crucial trial completed in 1999 showed that the patch delivered 30 to 38 micrograms of estrogen into the bloodstream each day, according to company documents.
High doses of estrogen are known to raise the risk for blood clots that can cause heart attacks and strokes.
Why didn't Johnson & Johnson inform the public quickly about these potential health risks?
Have you been harmed by the Ortho Evra birth-control patch? One of our Defective Drug and Medical Devices lawyer can help you file a lawsuit against the manufacturer.
Please complete the form below for a free legal evaluation of your case. A representative of our firm will be in touch with you shortly.
see also:
FDA Warning, 1.18.08
FDA: Ortho Evra Users at Higher Risk for VTE and Pulmonary EmbolismFDA Changes Ortho Evra label after second study cites pulmonary risk
Ortho Evra Lawyers
Know the Health Risk Associated With Ortho Evra Birth Control: LawyersOur defective drugs lawyers can help you file your Ortho Evra case
Updated FDA Warnings
FDA Continues to Update Warnings to Label of Ortho Evra--attorney infoRead on for information regarding Updated FDA Warnings to Ortho Evra
